TABLE 4.
Comparison of regimens with metronidazole and nitrofurantoin for the eradication of metronidazole-sensitive and -resistant H. pylori from mice
| Group | No. of mice | Inoculating suspension | Treatmenta | No. of mice infected with:
|
||
|---|---|---|---|---|---|---|
| H. pylorib | MTZ-resistant H. pylori | NF-resistant H. pylorid | ||||
| Control | 10 | PTB | PTB | 0 | 0 | 0 |
| 1 | 10 | H. pylori SS1 | PTB | 10 | 0 | 0 |
| 2 | 10 | H. pylori SS1-11 | PTB | 10 | 10 | 0 |
| 3 | 8 | H. pylori SS1 | OCM | 0e | 0 | 0 |
| 4 | 8 | H. pylori SS1-11 | OCM | 7e | 7 | 0 |
| 5 | 6 | H. pylori SS1 | OCNf | 6e | 0 | 0 |
| 6 | 7 | H. pylori SS1-11 | OCNf | 6 | 6 | 0 |
PTB, peptone-trypsin broth; OCM, omeprazole, clarithromycin, and metronidazole; OCNf, omeprazole, clarithromycin, and nitrofurantoin.
Number of mice infected with H. pylori 1 month after the completion of treatment.
Number of mice from which metronidazole (MTZ)-resistant strains were isolated.
Number of mice from which nitrofurantoin (NF)-resistant strains were isolated.
Statistically significant difference (P < 0.001).